Biopharmaceuticals
Regulatory
News Release - January 18, 2007
Cipralex Approved in Europe for the Treatment of Obsessive Compulsive Disorder
Source: H. Lundbeck
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.